Mustang Return On Equity from 2010 to 2024

MBIO Stock  USD 0.20  0.01  5.26%   
Mustang Bio Return On Equity yearly trend continues to be very stable with very little volatility. Return On Equity is likely to grow to -398.55 this year. Return On Equity is a measure of the profitability of Mustang Bio in relation to the equity, calculated by dividing net income by shareholder's equity. View All Fundamentals
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(419.53)
Current Value
(398.55)
Quarterly Volatility
144.00533632
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mustang Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mustang Bio's main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Selling General Administrative of 9 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 99.16. Mustang financial statements analysis is a perfect complement when working with Mustang Bio Valuation or Volatility modules.
  
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.

Latest Mustang Bio's Return On Equity Growth Pattern

Below is the plot of the Return On Equity of Mustang Bio over the last few years. Return on Equity is the amount of Mustang Bio net income returned as a percentage of Mustang Bio equity. Return on equity measures Mustang Bio profitability by revealing how much profit Mustang Bio generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Mustang Bio's Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mustang Bio's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported -11.9110 Years Trend
Slightly volatile
   Return On Equity   
       Timeline  

Mustang Return On Equity Regression Statistics

Arithmetic Mean(54.49)
Coefficient Of Variation(264.29)
Mean Deviation94.55
Median(0.52)
Standard Deviation144.01
Sample Variance20,738
Range421
R-Value(0.59)
Mean Square Error14,466
R-Squared0.35
Significance0.02
Slope(19.11)
Total Sum of Squares290,326

Mustang Return On Equity History

2024 -398.55
2023 -419.53
2022 -1.7
2021 -0.57
2020 -0.63
2019 -0.93
2018 -0.84

About Mustang Bio Financial Statements

Mustang Bio investors utilize fundamental indicators, such as Return On Equity, to predict how Mustang Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Return On Equity(419.53)(398.55)

Pair Trading with Mustang Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mustang Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will appreciate offsetting losses from the drop in the long position's value.

Moving against Mustang Stock

  0.51WAT WatersPairCorr
  0.43BMY Bristol Myers Squibb Sell-off TrendPairCorr
  0.37BHC Bausch Health CompaniesPairCorr
  0.32VTRS ViatrisPairCorr
  0.32ESPR Esperion Therapeutics Buyout TrendPairCorr
The ability to find closely correlated positions to Mustang Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mustang Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mustang Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mustang Bio to buy it.
The correlation of Mustang Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mustang Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mustang Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mustang Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock:
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.33)
Revenue Per Share
(0)
Return On Assets
(0.97)
Return On Equity
(11.91)
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.